So far, China has made no official public threat about weaponizing its dominant position in this segment of the ...

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) and Nanjing Chia Tai Tianqing Pharmaceutical Co., ...

In recent years, Chinese investment in U.S. and global biotech and medtech has increased significantly. These partnerships ...

Biocytogen secures Japanese patent for RenMab platform; expands global patent portfolio for RenMice fully human antibody: Beijing Saturday, June 7, 2025, 11:00 Hrs [IST] Biocytoge ...

As a leader in its category, Sinotau is probably hoping to follow in the footsteps of Hengrui Pharmaceuticals (1276.HK; ...

U.S. dependency on China for critical goods like rare earths and pharmaceuticals poses risks. Trump's strategies aim to ...

Co., Ltd. (Biocytogen, HKEX: 02315) today announced that the key technology of its independently developed RenMab™ fully ...

Adani Group stocks, United Breweries, HCL Tech, Glenmark Pharma, NTPC Green and Jindal Stainless are among the stocks to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

White House officials will press China to hasten exports of rare earths and magnets and stick to an agreement the countries ...

Global Dermatology Devices Market is expected to grow at a rate of 12% by 2026. Growing awareness on dermatology devices for aesthetic treatments, growing cases of skin diseases & skin cancer, ...

SINGAPORE—China is racing toward economic self-sufficiency by weaning itself off American technology. But it has made a ...